EDITORIAL
Published on 03 May 2021
Editorial: Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive Mechanisms
doi 10.3389/fimmu.2021.691899
- 1,579 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive Mechanisms
Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive Mechanisms
36k
Total downloads
119k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
MINI REVIEW
Published on 27 Jan 2021
Lysophosphatidic Acid Is an Inflammatory Lipid Exploited by Cancers for Immune Evasion via Mechanisms Similar and Distinct From CTLA-4 and PD-1
doi 10.3389/fimmu.2020.531910
- 3,808 views
- 17 citations
ORIGINAL RESEARCH
Published on 06 Oct 2020
The Oncometabolite 5′-Deoxy-5′-Methylthioadenosine Blocks Multiple Signaling Pathways of NK Cell Activation
doi 10.3389/fimmu.2020.02128
- 4,246 views
- 9 citations
REVIEW
Published on 16 Sep 2020
Pro-tumor γδ T Cells in Human Cancer: Polarization, Mechanisms of Action, and Implications for Therapy
doi 10.3389/fimmu.2020.02186
- 6,040 views
- 39 citations
ORIGINAL RESEARCH
Published on 03 Sep 2020
Identification of an Immune Signature Predicting Prognosis Risk and Lymphocyte Infiltration in Colon Cancer
doi 10.3389/fimmu.2020.01678
- 11,798 views
- 72 citations
REVIEW
Published on 14 Aug 2020
Specific Targeting of Notch Ligand-Receptor Interactions to Modulate Immune Responses: A Review of Clinical and Preclinical Findings
doi 10.3389/fimmu.2020.01958
- 4,354 views
- 17 citations
MINI REVIEW
Published on 28 Jul 2020
Re-education of the Tumor Microenvironment With Targeted Therapies and Immunotherapies
doi 10.3389/fimmu.2020.01633
- 6,689 views
- 35 citations
REVIEW
Published on 07 Jul 2020
Clinical and Recent Patents Applications of PD-1/PD-L1 Targeting Immunotherapy in Cancer Treatment—Current Progress, Strategy, and Future Perspective
doi 10.3389/fimmu.2020.01508
- 15,209 views
- 70 citations
CASE REPORT
Published on 07 Jul 2020
Somatostatin Receptors in Merkel-Cell Carcinoma: A Therapeutic Opportunity Using Somatostatin Analog Alone or in Association With Checkpoint Inhibitors Immunotherapy. A Case Report
doi 10.3389/fonc.2020.01073
- 2,495 views
- 13 citations
CASE REPORT
Published on 19 Jun 2020
Durable Response and Good Tolerance to the Triple Combination of Toripalimab, Gemcitabine, and Nab-Paclitaxel in a Patient With Metastatic Pancreatic Ductal Adenocarcinoma
doi 10.3389/fimmu.2020.01127
- 3,361 views
- 10 citations
REVIEW
Published on 29 May 2020
Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade
doi 10.3389/fimmu.2020.01075
- 9,251 views
- 45 citations
REVIEW
Published on 15 May 2020
TNFSF14: LIGHTing the Way for Effective Cancer Immunotherapy
doi 10.3389/fimmu.2020.00922
- 14,373 views
- 66 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 119kTopic views
- 80kArticle views
- 36kArticle downloads